主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ACRS
#2713
Aclaris Therapeutics, Inc.
2.8
7
-8.01%
版块:
基础:
利润货币:
日范围
年范围
日变化
-8.01%
每月变动
-26.41%
6个月变化
+56.83%
年变化
+50.26%
前一天收盘价
3.1
2
Open
2.8
7
Bid
Ask
Low
2.8
7
High
2.8
7
交易量
58
市场
股票
医疗保健
ACRS
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
新闻
Stifel因管线前景上调Aclaris Therapeutics目标价至3美元
Stifel raises Aclaris Therapeutics stock price target to $3 on pipeline
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates
Aclaris TherapeuticsQ4每股收益及营收逊于预期
Aclaris Therapeutics Inc earnings missed by $0.01, revenue fell short of estimates
Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates
Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates
Aclaris启动ATI-052治疗哮喘患者的1b期试验
Aclaris starts phase 1b trial of ATI-052 in asthma patients
Craig-Hallum 以"买入"评级开始对 Aclaris Therapeutics 股票的覆盖
Craig-Hallum initiates coverage on Aclaris Therapeutics stock with Buy rating
Aclaris stock gets Buy rating reaffirmed by H.C. Wainwright after positive preclinical results